Clinical trial
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast…
NCT00376805 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00376805 |
|---|---|
| Title | Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer |
| Official title | Allogeneic Natural Killer Cells in Patients With Advanced Metastatic Breast Cancer |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Other, Radiation |
| Interventions | Fludarabine, Cyclophosphamide, Total body irradiation, Natural killer cell infusion, Interleukin-2 |
| Enrollment | 6 |
| Start date | Apr 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Sep 15, 2006 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: